Understanding Pancreatic Cancer Prognosis
Mutations in four main genes influence survival rates of pancreatic adenocarcinoma patients
Roisin McGuigan |
Despite increased research efforts in recent years, survival rates for pancreatic cancer remain relatively low, with only 3.3 percent of adults surviving for five years with the disease (1), and researchers around the globe are working hard on new directions to aid in diagnosis, prognosis and treatment.
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!